HIMS

26.99

11.12% 2.70

Handel nachbörslich: 26.68 -0.31 -1.15%

Hims Hers Health Inc (HIMS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt HIMS? Forum Prognose

Schlusskurs vom Vortag:

$24.29

Offen:

$26.15

24-Stunden-Volumen:

79.95M

Relative Volume:

2.32

Marktkapitalisierung:

$6.15B

Einnahmen:

$2.35B

Nettoeinkommen (Verlust:

$128.37M

KGV:

51.70

EPS:

0.5221

Netto-Cashflow:

$57.42M

1W Leistung:

+36.66%

1M Leistung:

+8.48%

6M Leistung:

-54.37%

1J Leistung:

+0.15%

1-Tages-Spanne:

$24.76

$27.81

1-Wochen-Bereich:

$19.18

$27.81

52-Wochen-Spanne:

$13.74

$70.43

Hims Hers Health Inc Stock (HIMS) Company Profile

Firmenname

Hims Hers Health Inc

Sektor

Healthcare (1111)

Branche

Drug Manufacturers - Specialty & Generic (84)

Telefon

415-851-0195

Adresse

2269 CHESTNUT ST, SAN FRANCISCO

Mitarbeiter

2,442

Twitter

Nächster Verdiensttermin

2025-02-24

Neueste SEC-Einreichungen

HIMS's Discussions on Twitter

Compare HIMS vs TAK, ZTS, HLN, TEVA, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HIMS Hims Hers Health Inc	26.99	5.54B	2.35B	128.37M	57.42M	0.5221
TAK Takeda Pharmaceutical Co Adr	17.78	56.39B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	119.04	50.78B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.59	43.02B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	31.26	36.81B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	580.51	25.31B	3.18B	1.33B	1.04B	27.90

Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-03-10	Hochstufung	BofA Securities	Underperform → Neutral
2026-03-10	Hochstufung	Citigroup	Sell → Neutral
2026-03-09	Hochstufung	Needham	Hold → Buy
2026-02-24	Herabstufung	BTIG Research	Buy → Neutral
2026-01-12	Eingeleitet	Evercore ISI	In-line
2025-12-09	Eingeleitet	Barclays	Overweight
2025-10-21	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2025-06-23	Herabstufung	Needham	Buy → Hold
2025-06-04	Bestätigt	Needham	Buy
2025-04-29	Herabstufung	TD Cowen	Buy → Hold
2025-02-18	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2025-01-10	Herabstufung	Citigroup	Neutral → Sell
2025-01-07	Eingeleitet	BTIG Research	Buy
2024-12-17	Eingeleitet	Morgan Stanley	Overweight
2024-11-14	Herabstufung	BofA Securities	Buy → Underperform
2024-08-22	Eingeleitet	Needham	Buy
2024-08-09	Herabstufung	Imperial Capital	Outperform → In-line
2024-05-22	Herabstufung	Citigroup	Buy → Neutral
2024-04-16	Herabstufung	Jefferies	Buy → Hold
2024-04-10	Eingeleitet	Canaccord Genuity	Buy
2024-02-28	Hochstufung	Imperial Capital	In-line → Outperform
2024-02-26	Eingeleitet	Leerink Partners	Market Perform
2023-12-07	Eingeleitet	Imperial Capital	In-line
2023-07-28	Eingeleitet	TD Cowen	Outperform
2023-04-11	Eingeleitet	Robert W. Baird	Neutral
2023-02-09	Hochstufung	Jefferies	Hold → Buy
2022-11-08	Hochstufung	BofA Securities	Neutral → Buy
2022-11-08	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2022-10-17	Herabstufung	Piper Sandler	Overweight → Neutral
2022-09-07	Eingeleitet	Truist	Hold
2022-07-15	Eingeleitet	SVB Leerink	Underperform
2022-04-14	Eingeleitet	Guggenheim	Buy
2022-04-01	Fortgesetzt	Credit Suisse	Outperform
2022-03-10	Eingeleitet	Deutsche Bank	Hold
2021-12-02	Eingeleitet	Jefferies	Hold
2021-11-11	Hochstufung	Piper Sandler	Neutral → Overweight
2021-07-06	Eingeleitet	BofA Securities	Neutral
2021-05-20	Hochstufung	Credit Suisse	Neutral → Outperform
2021-04-21	Eingeleitet	Truist	Hold
2021-03-09	Eingeleitet	Credit Suisse	Neutral
2021-03-02	Hochstufung	Citigroup	Neutral → Buy
2021-02-17	Eingeleitet	Citigroup	Neutral
2021-02-12	Eingeleitet	Piper Sandler	Neutral
2021-02-08	Eingeleitet	Tigress Financial	Buy

Alle ansehen

Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten

05:35 AM

HIMS Stock Rises 7% on Potential FDA Regulatory Changes - GuruFocus

05:35 AM

05:34 AM

Eli Lilly's Oral Drug Clears CV Test, Hims Surges 14% - Gotrade

05:34 AM

05:17 AM

Stock Market Today, April 16: Hims & Hers Health Jumps on FDA Review of Compounded Peptide Therapies - Yahoo Finance

05:17 AM

04:23 AM

These Stocks Are Today’s Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More - Barron's

04:23 AM

03:30 AM

What's Going On With Hims & Hers Stock Thursday - GuruFocus

03:30 AM

03:22 AM

RFK Jr. Just Gave Hims & Hers Stock a Jolt. Should You Chase the Rally Here? - Barchart.com

03:22 AM

01:14 AM

Best Healthcare Stocks To Watch NowApril 16th - MarketBeat

01:14 AM

12:30 PM

HIMS: Positive Regulatory Developments Boost Stock Outlook - GuruFocus

12:30 PM

12:03 PM

Leerink reiterates Hims and Hers stock rating on peptide outlook - Investing.com

12:03 PM

11:58 AM

Hims & Hers Stock: How RFK Jr Loosened Peptide Regulations and Sent Shares Higher - Barron's

11:58 AM

11:41 AM

HIMS Stock Surges as FDA Plans Review on Peptide Compounding - GuruFocus

11:41 AM

11:35 AM

Hims rises as FDA considers broader peptides access; analysts see long-term win - Reuters

11:35 AM

11:33 AM

Hims & Hers (HIMS) Stock; Climbs 8% as FDA Peptide Review Sparks Expansion Hopes - CoinCentral

11:33 AM

10:45 AM

Hims & Hers stock extends gains as RFK Jr. signals FDA will consider looser restrictions on peptides - Yahoo Finance

10:45 AM

10:44 AM

Hims stock gains as FDA reviews peptides, Voyager secures NASA contract - Yahoo Finance

10:44 AM

10:37 AM

Hims & Hers extends gains on optimism over FDA peptide - Yahoo Finance

10:37 AM

10:34 AM

BofA Raises Hims & Hers Target to $25 as FDA Takes a Step Toward Wellness Peptides: Is a New Revenue Boom Coming? - Yahoo Finance

10:34 AM

10:32 AM

Biggest stock movers Thursday: AEHR, ABT, HOOD, COIN, and more (NYSE:HIMS) - Seeking Alpha

10:32 AM

10:30 AM

Market movers: Hims & Hers, Abbott Laboratories, QVC… - Proactive financial news

10:30 AM

10:14 AM

Bank of America Issues Positive Forecast for Hims & Hers Health (NYSE:HIMS) Stock Price - MarketBeat

08:21 AM

08:09 AM

FDA Peptide Review, A Big Moment For Hims & Hers (Rating Upgrade) - Seeking Alpha

08:09 AM

07:22 AM

Hims & Hers (HIMS) Stock Jumps 13% as FDA Opens Door to Peptide Review - CoinCentral

07:22 AM

06:46 AM

HIMS Shares Surge 11% on FDA Regulatory News - GuruFocus

06:46 AM

06:42 AM

Hims & Hers (HIMS) Shares Surge on FDA Peptide Regulation Update - GuruFocus

06:42 AM

06:28 AM

Why Is Hims & Hers Stock Soaring After FDA's Announcment? - Benzinga

06:28 AM

05:15 AM

Hims & Hers on track to extend gains as RFK Jr. seeks to loosen peptide regulations (HIMS:NYSE) - Seeking Alpha

05:15 AM

04:57 AM

Hims Jumps as RFK Jr. Seeks to Loosen Peptide Regulations - The Business of Fashion

04:57 AM

04:28 AM

Hims & Hers shares rise 11% on FDA peptide restriction changes - Investing.com

04:28 AM

Apr 15, 2026

Hims & Hers Providers Can't Duck Suit Over Student's Suicide - Law360

Apr 15, 2026

Allbirds, Hims & Hers, Microsoft, Xanadu Quantum And Tesla: Why These 5 Stocks Are On Investors' Radars Today - Benzinga

Apr 15, 2026

Why Is HIMS Stock Surging More Than 11% After-Hours Today? - Stocktwits

Apr 15, 2026

A Look at Hims & Hers Health Inc (HIMS) After 13.7% Gain -- GF V - GuruFocus

Apr 15, 2026

Investors Purchase Large Volume of Call Options on Hims & Hers Health (NYSE:HIMS) - MarketBeat

Apr 15, 2026

Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides - MarketWatch

Apr 15, 2026

Applauding FDA's Move Towards Regulatory Clarity on Peptide Therapy - Hims & Hers Newsroom

Apr 15, 2026

FDA sets up AdCom meeting to decide on lifting restrictions on certain peptides - Seeking Alpha

Apr 15, 2026

Hims & Hers Health stock gains as ZAVA and Livewell acquisitions boost international sales - Traders Union

Apr 15, 2026

Why is Hims & Hers Health stock up today? - Traders Union

Apr 15, 2026

Apr 14, 2026

Hims & Hers: Bargain EBITDA Multiples As GLP-1 Drama Passes - Seeking Alpha

Apr 14, 2026

Hims Didn't Protect Customer Data From Hackers, Suit Says - Law360

Apr 14, 2026

Hims & Hers Powers Patient-Provider Connectivity via Digital Platforms - The Globe and Mail

Apr 14, 2026

Modest gains for Hims & Hers Health stock as $21.38 resistance remains in focus - Traders Union

Apr 14, 2026

Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know - Yahoo Finance

Apr 14, 2026